PMID- 18722223 OWN - NLM STAT- MEDLINE DCOM- 20081009 LR - 20131121 IS - 0194-5998 (Print) IS - 0194-5998 (Linking) VI - 139 IP - 3 DP - 2008 Sep TI - Double-blind, placebo-controlled trial with esomeprazole for symptoms and signs associated with laryngopharyngeal reflux. PG - 414-20 LID - 10.1016/j.otohns.2008.06.003 [doi] AB - OBJECTIVE: To determine the efficacy of proton pump inhibitor (PPI) therapy with esomeprazole on symptoms and signs associated with laryngopharyngeal reflux (LPR). STUDY DESIGN AND METHODS: Prospective, double-blind, randomized, placebo-controlled study. Sixty-two patients with a reflux finding score (RFS)>7 and a reflux symptom index (RSI)>13 were enrolled and received either esomeprazole 20 mg twice daily or placebo for three months. RSI and RFS were assessed at baseline, after six weeks, and after three months. RESULTS: Reductions of total RSI and RFS as well as of several subscores were significantly higher in the treatment group compared to placebo after three months (P<0.05 each). The difference between study groups was most pronounced for posterior commissure hypertrophy (P<0.01). CONCLUSION: In the treatment of LPR-related symptoms a high placebo effect can be observed. However, compared to control, twice-daily PPI treatment for three months demonstrated a significantly greater improvement in laryngeal appearance and LPR symptoms. FAU - Reichel, Oliver AU - Reichel O AD - Department of Otorhinolaryngology-Head and Neck Surgery, Ludwig Maximilians University, Munich, Germany. Oliver.Reichel@med.uni-muenchen.de FAU - Dressel, Holger AU - Dressel H FAU - Wiederanders, Katrin AU - Wiederanders K FAU - Issing, Wolfgang J AU - Issing WJ LA - eng PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, Non-U.S. Gov't PL - England TA - Otolaryngol Head Neck Surg JT - Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery JID - 8508176 RN - 0 (Anti-Ulcer Agents) RN - 0 (Proton Pump Inhibitors) RN - N3PA6559FT (Esomeprazole) SB - IM CIN - Z Gastroenterol. 2008 Dec;46(12):1404-5. PMID: 19053010 MH - Adult MH - Aged MH - Anti-Ulcer Agents/administration & dosage/*therapeutic use MH - Double-Blind Method MH - Esomeprazole/administration & dosage/*therapeutic use MH - Female MH - Gastroesophageal Reflux/*drug therapy MH - Humans MH - Hypertrophy MH - Hypopharynx/drug effects/pathology/physiopathology MH - Male MH - Middle Aged MH - Prospective Studies MH - Proton Pump Inhibitors/administration & dosage/*therapeutic use EDAT- 2008/08/30 09:00 MHDA- 2008/10/10 09:00 CRDT- 2008/08/30 09:00 PHST- 2008/04/09 00:00 [received] PHST- 2008/05/27 00:00 [revised] PHST- 2008/06/03 00:00 [accepted] PHST- 2008/08/30 09:00 [pubmed] PHST- 2008/10/10 09:00 [medline] PHST- 2008/08/30 09:00 [entrez] AID - S0194-5998(08)01072-3 [pii] AID - 10.1016/j.otohns.2008.06.003 [doi] PST - ppublish SO - Otolaryngol Head Neck Surg. 2008 Sep;139(3):414-20. doi: 10.1016/j.otohns.2008.06.003.